(As of 12/31/2022)

Manulife Global Monthly High Inc Fd Advisor Ser

(Global Neutral Balanced)
FundGrade A+® Rating recipient
For more information about FundGrade click here
2020





Inception Return
(8/23/2011)
6.43 %
YTD Return -19.05 %
NAVPS
(2/6/2023)
$14.07
Change ($0.05) / -0.33 %
Growth of $10,000 (As of December 31, 2022)
MER 2.34 %
Assets ($mil) $653.43
Rank (1Yr) 1711/1734
Std Dev (3Yr) 11.11 %
Volatility Ranking (3Yr) 5/10
RRSP Eligibility Yes
Load Choice of Front or Back
Max Front End 5.00 %
Max Back End 6.00 %
Sales Status Open
 
Objective
The fundamental investment objective of the Fund is to seek to provide long-term total return by investing primarily in a diversified portfolio of Canadian and foreign equity, fixed income and money market securities.
Fund Manager

Manulife Investment Management Limited

Portfolio Manager

Alan Wicks, Manulife Investment Management Limited

Chris Hensen, Manulife Investment Management Limited

Terry Carr, Manulife Investment Management Limited

Prakash Chaudhari, Manulife Investment Management Limited

Jonathan Popper, Manulife Investment Management Limited

Conrad Dabiet, Manulife Investment Management Limited

Saurabh Moudgil, Manulife Investment Management Limited

Sub-Advisor

Manulife Investment Management (US) LLC

Manulife Investment Management (Hong Kong) Limited

 
Asset Allocation
(As of November 30, 2022)
Sector Allocation
(As of November 30, 2022)
Geographic Allocation
(As of November 30, 2022)
Top 10 Holdings
NameAssetSectorGeographicPercent
Aon PLC Cl AInternational EquityFinancial ServicesEuropean Union0.00%
Marsh & McLennan Cos IncUS EquityFinancial ServicesUnited States0.00%
Cintas CorpUS EquityIndustrial ServicesUnited States0.00%
Microsoft CorpUS EquityTechnologyUnited States0.00%
Bunzl PLCInternational EquityIndustrial ServicesEuropean Union0.00%
McKesson CorpUS EquityConsumer ServicesUnited States0.00%
Berkshire Hathaway Inc Cl BUS EquityFinancial ServicesUnited States0.00%
Wolters Kluwer NV Cl CInternational EquityIndustrial ServicesEuropean Union0.00%
Thermo Fisher Scientific IncUS EquityHealthcareUnited States0.00%
Charles Schwab CorpUS EquityFinancial ServicesUnited States0.00%

Performance Data (As of December 31, 2022)
  Return (%) Annualized Return (%)
Return 1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr
Fund -3.20 3.83 2.87 -19.05 -19.05 4.50 4.28 6.21
Benchmark -1.82 6.09 5.20 -11.62 -11.62 1.50 3.81 7.69
Quartile Ranking 4 3 3 4 4 1 1 1

Calendar Return (%) 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Fund -19.05 13.62 24.09 13.30 -4.64 21.67 1.09 -0.67 -0.07 21.36
Benchmark -11.62 6.48 11.12 12.26 2.68 8.66 2.39 17.05 12.44 18.86
Quartile Ranking 4 1 1 2 4 1 4 4 4 1

Website powered by © Fundata Canada Inc.
Mutual Fund Data provided by Fundata. | View Terms and Conditions of Use.
BofA Merill Lynch Indices used with permission.
© 2023 Fundata Canada Inc. All rights reserved. | View Privacy Policy | Contact Us.